Patent details

EP2968484 Title: TREATMENT METHOD AND PRODUCT FOR UTERINE FIBROIDS USING PURIFIED COLLAGENASE

Basic Information

Publication number:
EP2968484
PCT Application Number:
US2014029448
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP147216642
PCT Publication Number:
WO2014144859
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT METHOD AND PRODUCT FOR UTERINE FIBROIDS USING PURIFIED COLLAGENASE
French Title of Invention:
PROCÉDÉ ET PRODUIT DE TRAITEMENT POUR FIBROÏDES UTÉRINS AU MOYEN DE COLLAGÉNASE PURIFIÉE
German Title of Invention:
BEHANDLUNGSVERFAHREN UND PRODUKT FÜR GEBÄRMUTTERFIBROME MIT GEREINIGTER KOLLAGENASE
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
25/11/2020
EP Publication Date:
20/01/2016
PCT Publication Date:
18/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/11/2020
EP B1 Publication Date:
25/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/11/2020
 
 

Name:
BioSpecifics Technologies Corporation
Address:
35 Wilbur Street, Lynbrook, NY 11563, United States (US)

Name:
Duke University
Address:
35 Wilbur Street, Durham, NC 27708, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
31/12/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LEPPERT, Phyllis, Carolyn
Address:
United States (US)

2

Name:
WEGMAN, Thomas, L.
Address:
United States (US)

Priority

Priority Number:
201361790070 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 38/43; A61K 38/48; A61K 45/06; A61P 15/00; A61P 35/00; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202048
Publication date:
25/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/02/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
31/12/2020 Outgoing Correspondence 1
31/12/2020 Power Of Attorney 1